SBHMY•United States•Healthcare•United States•$22.32B

Stocks Similar to SBHMY

Top 20 stocks similar to Sino Biopharmaceutical Ltd ADR based on sector, industry, market cap, and valuation multiples. Same-industry peers (Biotechnology) are ranked first.

Company	Industry	Market Cap	P/E	Yield	Change	Compare
0Q Moderna, Inc. 0QF • Germany	Biotechnology	$22.78B	0.0	—	+4.34%	vs
BN BioNTech SE BNTX • United States	Biotechnology	$22.88B	0.0	—	+7.77%	vs
WuXi Biologics 2269 • Hong Kong	Biotechnology	$19.82B	28.2	—	-0.50%	vs
22 BioNTech SE 22UA • Germany	Biotechnology	$26.75B	0.0	—	+11.19%	vs
99 Akeso Inc 9926 • Hong Kong	Biotechnology	$17.16B	0.0	—	+9.26%	vs
69 Sichuan Kelun-Biotech 6990 • Hong Kong	Biotechnology	$15.42B	0.0	—	+5.48%	vs
AS Ascendis Pharma AS ASND • United States	Biotechnology	$13.87B	0.0	—	+2.17%	vs
BB BridgeBio Pharma Inc BBIO • United States	Biotechnology	$13.46B	0.0	—	+2.90%	vs
Akeso, Inc. AKESF • United States	Biotechnology	$13.13B	0.0	—	+9.85%	vs
01 SAMSUNG EPISHOLDINGS CO LTD 0126Z0 • South Korea	Biotechnology	$10.25B	0.0	—	+8.04%	vs
Samsung Biologics Co Ltd 207940 • South Korea	Biotechnology	$50.58B	0.0	—	+0.00%	vs
AB Abivax SA ABVX • France	Biotechnology	$9.79B	0.0	—	-2.97%	vs
ABIVAX Société Anonyme AAVXF • United States	Biotechnology	$9.56B	0.0	—	+0.00%	vs
Genmab A/S GMAB • Denmark	Biotechnology	$17.40B	18.2	—	+0.78%	vs
BM Biomarin Pharmaceutical Inc BMRN • United States	Biotechnology	$11.25B	32.5	—	+0.20%	vs
AB Abivax SA American Depositary Shares ABVX • United States	Biotechnology	$8.19B	0.0	—	-4.74%	vs
AX Axsome Therapeutics Inc AXSM • United States	Biotechnology	$7.98B	0.0	—	+6.11%	vs
60 Beijing Wantai Biological Pharmacy Enterprise Co Ltd 603392 • China	Biotechnology	$7.40B	0.0	—	+1.48%	vs
CY Cytokinetics Inc CYTK • United States	Biotechnology	$7.40B	0.0	—	+2.61%	vs
68 Shanghai Junshi Biosciences Co Ltd 688180 • China	Biotechnology	$6.77B	0.0	—	+18.28%	vs

How we rank similar stocks

Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.

View all Healthcare stocks →